490 related articles for article (PubMed ID: 27048998)
21. Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration.
Broadhead GK; Hong T; Zhu M; Li H; Schlub TE; Wijeyakumar W; Chang AA
Retina; 2015 May; 35(5):975-81. PubMed ID: 25627086
[TBL] [Abstract][Full Text] [Related]
22. QUANTITATIVE ANALYSIS OF PIGMENT EPITHELIAL DETACHMENT RESPONSE TO DIFFERENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN WET AGE-RELATED MACULAR DEGENERATION.
Balaskas K; Karampelas M; Horani M; Hotu O; Keane P; Aslam T
Retina; 2017 Jul; 37(7):1297-1304. PubMed ID: 27755376
[TBL] [Abstract][Full Text] [Related]
23. AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: The ARI2 Study.
Blanco-Garavito R; Jung C; Uzzan J; Quaranta-ElMaftouhi M; Coscas F; Sahel J; Korobelnik JF; Béchet S; Querques G; Souied EH
Retina; 2018 Dec; 38(12):2285-2292. PubMed ID: 29190241
[TBL] [Abstract][Full Text] [Related]
24. Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.
Despreaux R; Cohen SY; Semoun O; Zambrowski O; Jung C; Oubraham H; Souied EH
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):639-44. PubMed ID: 26092633
[TBL] [Abstract][Full Text] [Related]
25. Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results.
Chevreaud O; Oubraham H; Cohen SY; Jung C; Blanco-Garavito R; Gherdaoui F; Souied EH
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):743-751. PubMed ID: 27913869
[TBL] [Abstract][Full Text] [Related]
26. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
[TBL] [Abstract][Full Text] [Related]
27. Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
Gillies MC; Nguyen V; Daien V; Arnold JJ; Morlet N; Barthelmes D
Ophthalmology; 2016 Dec; 123(12):2545-2553. PubMed ID: 27707549
[TBL] [Abstract][Full Text] [Related]
28. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
[TBL] [Abstract][Full Text] [Related]
29. OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Khanani AM; Eichenbaum D; Schlottmann PG; Tuomi L; Sarraf D
Retina; 2018 Nov; 38(11):2103-2117. PubMed ID: 29697591
[TBL] [Abstract][Full Text] [Related]
30. Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors.
Ho VY; Yeh S; Olsen TW; Bergstrom CS; Yan J; Cribbs BE; Hubbard GB
Am J Ophthalmol; 2013 Jul; 156(1):23-28.e2. PubMed ID: 23664153
[TBL] [Abstract][Full Text] [Related]
31. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
[TBL] [Abstract][Full Text] [Related]
32. Quantification of Change in Pigment Epithelial Detachment Volume and Morphology After Transition to Intravitreal Aflibercept in Eyes With Recalcitrant Neovascular AMD: 18-Month Results.
Kanesa-Thasan A; Grewal DS; Gill MK; Lyon AT; Mirza RG
Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):638-41. PubMed ID: 26114844
[TBL] [Abstract][Full Text] [Related]
33. [Anti-VEGF-therapy of fibrovascular and serous-vascularized pigment epithelial detachment in neovascular AMD : A retrospective five-year-analysis].
Barth T; Reiners M; Zeman F; Greslechner R; Helbig H; Gamulescu MA
Ophthalmologe; 2021 Dec; 118(12):1255-1263. PubMed ID: 33320292
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment.
Zhao C; Zhang Z; Chen L; Wang F; Xu D
Med Sci Monit; 2016 Mar; 22():833-9. PubMed ID: 26972376
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept.
Chatziralli I; Nicholson L; Vrizidou E; Koutsiouki C; Menon D; Sergentanis TN; Citu MC; Hamilton R; Patel PJ; Hykin P; Sivaprasad S
Ophthalmology; 2016 Aug; 123(8):1762-1770. PubMed ID: 27289179
[TBL] [Abstract][Full Text] [Related]
36. Multilayered pigment epithelial detachment in neovascular age-related macular degeneration.
Rahimy E; Freund KB; Larsen M; Spaide RF; Costa RA; Hoang Q; Christakopoulos C; Munch IC; Sarraf D
Retina; 2014 Jul; 34(7):1289-95. PubMed ID: 24675391
[TBL] [Abstract][Full Text] [Related]
37. Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degeneration over 24 Months.
Garweg JG; Gerhardt C; Kodjikian L; Pfister IB
J Ocul Pharmacol Ther; 2017 Sep; 33(7):567-572. PubMed ID: 28557667
[TBL] [Abstract][Full Text] [Related]
38. [Intravitreal aflibercept in high retinal pigment epithelial detachments].
Boriskina LN; Khzardzhan YY; Zotov AS; Balalin AS; Kuznetsova NV
Vestn Oftalmol; 2018; 134(5):92-98. PubMed ID: 30499545
[TBL] [Abstract][Full Text] [Related]
39. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
[TBL] [Abstract][Full Text] [Related]
40. High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.
Muftuoglu IK; Tsai FF; Gaber R; Alam M; Meshi A; Freeman WR
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):709-717. PubMed ID: 27878592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
